Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Nature Cell Biology
|
May 11, 2026
Inflammation starves antitumour immunity
Dominic Denk, Michael Karin
Trends in Cancer
|
July 30, 2022
Inflammation: the incubator of the tumor microenvironment
Dominic Denk, Florian R Greten
Pharmaceutics
|
September 25, 2019
Theranostic Sorafenib-Loaded Polymeric Nanocarriers Manufactured by Enhanced Gadolinium Conjugation Techniques
Tivadar Feczkó, Albrecht Piiper, Thomas Pleli, et al.
JHEP Reports : Innovation in Hepatology
|
February 18, 2026
Co-administered internalizing RGD peptide boosts anti-PD-L1 therapy in hepatocellular carcinoma
Jan Henrik Klug, Blerina Aliraj, Lucia Alcober-Boquet, et al.
Immunity
|
March 1, 2025
IL-17RA signaling provides dual tumor-suppressor function during late-stage colorectal carcinogenesis
Dominic Denk, Mallika Ramakrishnan, Claire Conche, et al.
Immunity
|
November 9, 2022
Expansion of T memory stem cells with superior anti-tumor immunity by Urolithin A-induced mitophagy
Dominic Denk, Valentina Petrocelli, Claire Conche, et al.
Gut
|
January 27, 2023
Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade
Claire Conche, Fabian Finkelmeier, Marina Pešić, et al.
Ebiomedicine
|
June 18, 2024
Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in mice
Christian Schmithals, Bianca Kakoschky, Dominic Denk, et al.
Nature Aging
|
January 6, 2026
Author Correction: Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial
Dominic Denk, Anurag Singh, Herbert G Kasler, et al.
Nature Aging
|
November 1, 2025
Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial
Dominic Denk, Anurag Singh, Herbert G Kasler, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Nature Cell Biology
|
May 11, 2026
Inflammation starves antitumour immunity
Dominic Denk, Michael Karin
Trends in Cancer
|
July 30, 2022
Inflammation: the incubator of the tumor microenvironment
Dominic Denk, Florian R Greten
Pharmaceutics
|
September 25, 2019
Theranostic Sorafenib-Loaded Polymeric Nanocarriers Manufactured by Enhanced Gadolinium Conjugation Techniques
Tivadar Feczkó, Albrecht Piiper, Thomas Pleli, et al.
JHEP Reports : Innovation in Hepatology
|
February 18, 2026
Co-administered internalizing RGD peptide boosts anti-PD-L1 therapy in hepatocellular carcinoma
Jan Henrik Klug, Blerina Aliraj, Lucia Alcober-Boquet, et al.
Immunity
|
March 1, 2025
IL-17RA signaling provides dual tumor-suppressor function during late-stage colorectal carcinogenesis
Dominic Denk, Mallika Ramakrishnan, Claire Conche, et al.
Immunity
|
November 9, 2022
Expansion of T memory stem cells with superior anti-tumor immunity by Urolithin A-induced mitophagy
Dominic Denk, Valentina Petrocelli, Claire Conche, et al.
Gut
|
January 27, 2023
Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade
Claire Conche, Fabian Finkelmeier, Marina Pešić, et al.
Ebiomedicine
|
June 18, 2024
Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in mice
Christian Schmithals, Bianca Kakoschky, Dominic Denk, et al.
Nature Aging
|
January 6, 2026
Author Correction: Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial
Dominic Denk, Anurag Singh, Herbert G Kasler, et al.
Nature Aging
|
November 1, 2025
Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial
Dominic Denk, Anurag Singh, Herbert G Kasler, et al.
Page
of 1